|

The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)

RECRUITINGN/ASponsored by Institut de Recherche pour le Developpement
Actively Recruiting
PhaseN/A
SponsorInstitut de Recherche pour le Developpement
Started2024-03-18
Est. completion2025-05
Eligibility
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05951751

Summary

The TRI-MOM program aims to implement and evaluate a simplified (based on inexpensive rapid diagnostic tests), integrated (in governmental health facilities) and coordinated (between health care workers) strategy for the triple elimination of HIV, syphilis and HBV mother-to-child transmission (MTCT) in nine maternal and child health services, 5 in Burkina Faso and 5 in The Gambia. The TRI-MOM program has two components: 1. an "intervention" component consisting of a pilot study to reinforce the antenatal screening and prevention of MTCT (PMTCT) capacities for the 3 targeted infections through the implementation of a simplified, integrated and coordinated strategy of triple elimination of MTCT. 2. an "evaluation" component which will assess the impact of the TRI-MOM strategy on PMTCT services, reduction of HBV MTCT and women empowerment.

Eligibility

Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women attending a postnatal visit in one of the selected maternities (no maternal age limit)

Exclusion Criteria:

* Refusal to participate in the study
* Unable to provide consent

Conditions4

HBVHIVLiver DiseaseSyphilis

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.